Literature DB >> 24032001

Correcting the Results of the Wrong Model: Treatment Effects under Early Detection of Cancer.

Shih-Yuan Lee1, Alex Tsodikov.   

Abstract

Early detection of cancer leads to variability of the point of diagnosis advanced by the amount of the so-called lead time, a random variable. Estimated treatment effects by the proportional hazards (PH) model may be biased if this variability is ignored. We study how true and PH-estimated treatment effects differ in screened vs. unscreened populations and offer an approximate correction for the reported PH-based estimate that does not require raw data, targeting a meta-analysis-type application. We rely on a joint cancer incidence and survival model of prostate cancer to furnish key information for the correction. The procedure is applied to a series of prostate cancer data analyses using the PH models reported in the literature. Simulations are used for assessing the quality of the method and sensitivity analyses.

Entities:  

Keywords:  Bias; Early detection; Lead time; Misspecified model; Proportional hazards

Year:  2013        PMID: 24032001      PMCID: PMC3767486          DOI: 10.1080/15598608.2013.772033

Source DB:  PubMed          Journal:  J Stat Theory Pract        ISSN: 1559-8608


  9 in total

1.  Semiparametric models: a generalized self-consistency approach.

Authors:  A Tsodikov
Journal:  J R Stat Soc Series B Stat Methodol       Date:  2003-08-01       Impact factor: 4.488

2.  Radical prostatectomy versus watchful waiting in early prostate cancer.

Authors:  Anna Bill-Axelson; Lars Holmberg; Mirja Ruutu; Michael Häggman; Swen-Olof Andersson; Stefan Bratell; Anders Spångberg; Christer Busch; Stig Nordling; Hans Garmo; Juni Palmgren; Hans-Olov Adami; Bo Johan Norlén; Jan-Erik Johansson
Journal:  N Engl J Med       Date:  2005-05-12       Impact factor: 91.245

3.  A population model of prostate cancer incidence.

Authors:  A Tsodikov; A Szabo; J Wegelin
Journal:  Stat Med       Date:  2006-08-30       Impact factor: 2.373

4.  The impact of heterogeneity on the comparison of survival times.

Authors:  M Schumacher; M Olschewski; C Schmoor
Journal:  Stat Med       Date:  1987 Oct-Nov       Impact factor: 2.373

5.  Reconstructing PSA testing patterns between black and white men in the US from Medicare claims and the National Health Interview Survey.

Authors:  Angela B Mariotto; Ruth Etzioni; Martin Krapcho; Eric J Feuer
Journal:  Cancer       Date:  2007-05-01       Impact factor: 6.860

6.  Properties of proportional-hazards score tests under misspecified regression models.

Authors:  S W Lagakos; D A Schoenfeld
Journal:  Biometrics       Date:  1984-12       Impact factor: 2.571

7.  13-year outcomes following treatment for clinically localized prostate cancer in a population based cohort.

Authors:  Peter C Albertsen; James A Hanley; David F Penson; George Barrows; Judith Fine
Journal:  J Urol       Date:  2007-03       Impact factor: 7.450

8.  Long-term survival probability in men with clinically localized prostate cancer treated either conservatively or with definitive treatment (radiotherapy or radical prostatectomy).

Authors:  Ashutosh Tewari; Jay D Raman; Peter Chang; Sandhya Rao; George Divine; Mani Menon
Journal:  Urology       Date:  2006-12       Impact factor: 2.649

9.  Quantifying the role of PSA screening in the US prostate cancer mortality decline.

Authors:  Ruth Etzioni; Alex Tsodikov; Angela Mariotto; Aniko Szabo; Seth Falcon; Jake Wegelin; Dante DiTommaso; Kent Karnofski; Roman Gulati; David F Penson; Eric Feuer
Journal:  Cancer Causes Control       Date:  2007-11-20       Impact factor: 2.506

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.